Navigation Links
Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
Date:5/31/2012

MONMOUTH JUNCTION, N.J., May 31, 2012 /PRNewswire/ -- Tris Pharma, a technology driven specialty pharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved the first-ever generic to Delsym®, an extended-release oral liquid suspension containing dextromethorphan polistirex.

Delsym was approved in 1982 and there has never been any generic alternative approved until now. Tris has pioneered the delivery of drugs in taste-neutral, extended release dosage forms such as liquids, ODT/chewable tablets, and strips that are otherwise associated with immediate release. Tris' versatile, patented technology avoids the use of toxic organic solvents by employing aqueous-based coating.

"This is the third extended-release liquid product approved by the FDA based on our patented technology, and speaks to Tris' capabilities to develop and commercialize difficult products," said Ketan Mehta, President & CEO of Tris Pharma.  "Leveraging our technology, Tris has built a robust and deep pipeline of unique products that will address many of today's unmet needs."

Perrigo is Tris' exclusive partner in distributing this product as a store-brand alternative to Delsym, and has announced that it will be shipping the product for the coming cough/cold/flu season.  Annual sales across the entire Delsym brand are estimated at more than $100 million.

Delsym is a registered trademark of Reckitt Benckiser, which is not associated with Tris Pharma or Tris' generic product.

About Tris Pharma

Tris Pharma is a specialty pharmaceutical company focused on the research and development of technologies driven products. Tris has pioneered the delivery of sustained release in the liquid, chewable/ODT and strip dosage forms so patients do not have to swallow a pill. Tris' Nobuse technology provides abuse deterrence for opioids and other abuse-prone drugs. Tris' R&D and manufacturing facilities are located in Monmouth Junction, New Jersey, USA. For more information, please visit www.trispharma.com.


'/>"/>
SOURCE Tris Pharma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
2. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
3. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
4. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
5. Clean Room Environmental Best Practices for Medical Device & Pharmaceutical Manufacturers are Focus of Boston Seminar on June 6
6. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
7. Isis Pharmaceuticals to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
8. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
9. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
10. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
11. Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2020)... ... ... Planning an Audit Response:, How to Handle MDSAP Findings, An FDAnews Management ... spotted by a notified body during an audit does happen. What is the best ... pressure with only 15 days to craft a response to the auditing body. , ...
(Date:4/2/2020)... ... April 02, 2020 , ... Caitlin Richardson, a University ... Center's 2020 Spring Semester Scholarship. , The $1,000 scholarship, awarded biannually to ... is aimed at helping the students pay tuition and other college-related expenses. , ...
(Date:4/1/2020)... ... April 01, 2020 , ... ... is continuing her partnership with the esteemed Haute Beauty network. , The Haute ... present Dr. Green as a leading Anti-Aging Expert. , Haute Beauty offers a ...
Breaking Medicine Technology:
(Date:4/5/2020)... ... April 05, 2020 , ... In the midst of crisis, ... Nufabrx®, a proprietary biomaterial company that seamlessly embeds active ingredients including vitamins, supplements ... has shifted production for a new line of reusable copper medical masks called ...
(Date:4/2/2020)... ... April 02, 2020 , ... The Northern Virginia Community College ... from donor Debra Coffman Howe of Palm Beach, Florida. Ms. Howe is adding ... Supporting NOVA nursing is more important than ever given the current pandemic. Ms. ...
(Date:4/1/2020)... ... April 02, 2020 , ... Medical Device Change Management, ... https://www.fdanews.com/mdchangemanagement , What change management method should one be using for ... often dependent on the type of change. Is it due to post-market design change, ...
(Date:4/1/2020)... ... 01, 2020 , ... Global mobile data platform provider Zerion Software announced the ... needs based on COVID-19. , As cases continue to rise across the world, filling ... will extend support by offering free basic iFormBuilder accounts and forms - including HIPAA-compliant ...
(Date:3/28/2020)... N.J. (PRWEB) , ... March 27, 2020 , ... ... services division of the Suntuity Group of companies, is mobilizing their drone equipment ... COVID-19 coronavirus. , By leveraging their DJI Enterprise level Matrice and Agras drones, ...
Breaking Medicine News(10 mins):